0000884905-18-000077.txt : 20181101
0000884905-18-000077.hdr.sgml : 20181101
20181101170902
ACCESSION NUMBER: 0000884905-18-000077
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181031
FILED AS OF DATE: 20181101
DATE AS OF CHANGE: 20181101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roby Anne K
CENTRAL INDEX KEY: 0001595290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11037
FILM NUMBER: 181154701
MAIL ADDRESS:
STREET 1: 39 OLD RIDGEBURY ROAD
CITY: DANBURY
STATE: CT
ZIP: 06810-5113
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PRAXAIR INC
CENTRAL INDEX KEY: 0000884905
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INORGANIC CHEMICALS [2810]
IRS NUMBER: 061249050
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 RIVERVIEW DRIVE
CITY: DANBURY
STATE: CT
ZIP: 06810
BUSINESS PHONE: 2038372000
MAIL ADDRESS:
STREET 1: 10 RIVERVIEW DRIVE
CITY: DANBURY
STATE: CT
ZIP: 06810
FORMER COMPANY:
FORMER CONFORMED NAME: UNION CARBIDE INDUSTRIAL GASES INC
DATE OF NAME CHANGE: 19600201
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-10-31
1
0000884905
PRAXAIR INC
PX
0001595290
Roby Anne K
C/O PRAXAIR, INC.
10 RIVERVIEW DRIVE
DANBURY
CT
06810
0
1
0
0
Senior Vice President
Common Stock
2018-10-31
4
D
0
1328.5434
0
D
0
I
401(k)
Common Stock
2018-10-31
4
D
0
26747.951
0
D
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
3885
0
D
Common Stock
3885
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
3510
0
D
Common Stock
3510
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
4328
0
D
Common Stock
4328
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
3588
0
D
Common Stock
3588
0
D
Restricted Stock Units
0
2018-10-31
4
D
0
2960
0
D
Common Stock
2960
0
D
Stock Option (right to buy)
97.84
2018-10-31
4
D
0
13195
D
2021-02-22
Common Stock
13195
0
D
Stock Option (right to buy)
109.68
2018-10-31
4
D
0
18430
D
2022-02-28
Common Stock
18430
0
D
Stock Option (right to buy)
110.58
2018-10-31
4
D
0
15790
D
2023-02-26
Common Stock
15790
0
D
Stock Option (right to buy)
128.80
2018-10-31
4
D
0
19900
D
2024-02-25
Common Stock
19900
0
D
Stock Option (right to buy)
128.38
2018-10-31
4
D
0
26490
D
2025-02-24
Common Stock
26490
0
D
Stock Option (right to buy)
102.22
2018-10-31
4
D
0
49405
D
2026-02-23
Common Stock
49405
0
D
Stock Option (right to buy)
118.71
2018-10-31
4
D
0
39585
D
2027-02-28
Common Stock
39585
0
D
Stock Option (right to buy)
154.00
2018-10-31
4
D
0
32335
D
2028-02-27
Common Stock
32335
0
D
Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the Business Combination, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock Units that were previously awarded by Praxair, Inc. will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.
This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Anthony M. Pepper, Attorney-in-Fact
2018-11-01